Effect of Pingchuan Formula on MMP-9, TIMP-1, E-cadherin and CollagenⅠ in asthmatic mice at acute stage

Yan YANG; Zheng XUE; Jianer YU; Yizhong HU; Yazun LIU; Wanchao XU

doi:10.16305/j.1007-1334.2021.2009038

您当前的位置：

首页 >

文章列表页 >

Effect of Pingchuan Formula on MMP-9, TIMP-1, E-cadherin and CollagenⅠ in asthmatic mice at acute stage

更新时间：2022-08-03

- Effect of Pingchuan Formula on MMP-9, TIMP-1, E-cadherin and CollagenⅠ in asthmatic mice at acute stage
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 6, Pages: 67-71(2021)
- 作者机构：
  
  1.上海中医药大学附属市中医医院儿科（上海　200071）
  2.上海中医药大学研究生院（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2009038
  CLC：
扫描看全文
Yan YANG, Zheng XUE, Jianer YU, et al. Effect of Pingchuan Formula on MMP-9, TIMP-1, E-cadherin and CollagenⅠ in asthmatic mice at acute stage. [J]. Shanghai Journal of Traditional Chinese Medicine 55(6):67-71(2021)
DOI：

Yan YANG, Zheng XUE, Jianer YU, et al. Effect of Pingchuan Formula on MMP-9, TIMP-1, E-cadherin and CollagenⅠ in asthmatic mice at acute stage. [J]. Shanghai Journal of Traditional Chinese Medicine 55(6):67-71(2021) DOI： 10.16305/j.1007-1334.2021.2009038.

摘要

目的,2,通过检测小鼠肺组织中基质金属蛋白酶9（MMP-9）、金属蛋白酶组织抑制因子1（TIMP-1）、E-钙黏蛋白（E-cadherin）、Ⅰ型胶原（CollagenⅠ）的蛋白表达水平，探讨平喘方对哮喘急性发作期小鼠气道重塑的作用机制。,方法,2,将40只Balb/c雄性小鼠按随机数字表分为空白组、模型组、地塞米松组、平喘方组，每组10只。除空白组外，其余组均采用OVA“致敏＋激发”建立哮喘模型。灌胃给药干预1周后，采用Masson染色观察肺组织病理变化，ELISA法检测血小板衍生生长因子（PDGF）水平，Western blot法检测MMP-9、TIMP-1、E-cadherin、CollagenⅠ蛋白含量。,结果,2,空白组可见少许淡蓝色胶原纤维，胶原容积分数（CVF）最小，与空白组比较，模型组胶原纤维面积明显增多（,P,<,0.01），颜色更深；与模型组比较，地塞米松组、平喘方组小鼠胶原纤维面积明显较少（,P,<,0.01）。与空白组比较，模型组小鼠PDGF因子水平、MMP-9、TIMP-1、CollagenⅠ蛋白表达水平显著上升（,P,<,0.01），E-cadherin蛋白表达水平显著降低（,P,<,0.01）；与模型组比较，地塞米松组及平喘方组小鼠PDGF因子水平、TIMP-1、CollagenⅠ均显著下降（,P,<,0.01，,P,<,0.05），E-cadherin蛋白表达水平均显著上升（,P,<,0.01），地塞米松组MMP-9蛋白表达水平显著升高（,P,<,0.01），平喘方组MMP-9蛋白水平升高，但不显著（,P,>,0.05）。,结论,2,在哮喘急性发作期，平喘方可通过抑制PDGF的释放，降低MMP-9、TIMP-1、CollagenⅠ的表达以及上调E-cadherin的表达来缓解气道重塑，从而发挥哮喘治疗作用，为化痰药与祛瘀药相配治疗哮喘提供了理论依据。

Abstract

Objective,2,To explore the mechanism of Pingchuan Formula on airway remodeling in mice with acute asthma attacks by detecting the expression levels of matrix metalloproteinase 9 (MMP-9), tissue inhibitor of matrix metalloprotease-1 (TIMP-1), E-cadherin and collagen type Ⅰ (Collagen Ⅰ) proteins in the lung tissue of mice.,Methods,2,According to the random number table, 40 Balb/c male mice were divided into blank group, model group, dexamethasone group and Pingchuan Formula group, with 10 mice in each group. The groups except the blank group were modeled by OVA "sensitization + stimulation" . After 1 week of gavage administration, the lung tissue pathology was observed by Masson staining. The level of platelet-derived growth factor (PDGF) was detected by ELISA method. The protein contents of MMP-9, TIMP-1, E-cadherin and Collagen Ⅰ was detected by Western blot method.,Results,2,Some light blue collagen fibers could be seen in the blank group, and the collagen volume fraction(CVF) was the smallest. Compared with the blank group, the area of collagen fibers in the model group was significantly increased (,P,<,0.01), and the color was darker; compared with the model group, the area of collagen fibers in the dexamethasone group and the Pingchuan Formula group was significantly decreased (,P,<,0.01). Compared with the blank group, the PDGF factor level and the MMP-9、TIMP-1、Collagen Ⅰ protein expression levels of mice in the model group increased significantly (,P,<,0.01), but the expression level of E-cadherin protein decreased significantly (,P,<,0.01); compared with the model group, the PDGF factor level and TIMP-1、Collagen Ⅰ protein expression levels of mice in dexamethasone group and Pingchuan Formula group decreased significantly (,P,<,0.01,P,<,0.05), and the E-cadherin protein expression level increased significantly (,P,<,0.01). The expression level of MMP-9 protein was significantly increased in dexamethasone group (,P,<,0.01), while that was increased but not significant in Pingchuan Formula group (,P,>,0.05).,Conclusion,2,Pingchuan Formula can relieve airway remodeling by inhibiting PDGF release, reducing MMP-9、TIMP-1、CollagenⅠ expression and up-regulating E-cadherin expression, which provides a theoretical evidence for the clinical use of phlegm-removing drugs combined with blood stasis -removing drugs in the treatment of asthma.

关键词

平喘方哮喘模型小鼠气道重塑基质金属蛋白酶9金属蛋白酶组织抑制因子1E-钙黏蛋白Ⅰ型胶原

Keywords

Pingchuan Formulaasthmamodel miceairway remodelingMMP-9TIMP-1E-cadherinCollagenⅠ

references

CHUNG F, WENZEL S, BROZEK J L. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma[J]. Eur Respir J, 2014, 43(2): 343-373.

OLIN J T, WECHSLER M E. Asthma: pathogenesis and novel drugs for treatment[J]. BMJ, 2014(349): g5517.

李利清，虞坚尔，王忆勤，等. 平喘方对支气管哮喘模型大鼠气道顺应性影响研究[J]. 中国现代临床医学，2006,5(11):4-6.

朱慧华，虞坚尔，张晓峰，等. 平喘方对支气管哮喘模型小鼠气道重建的影响[J]. 中西医结合学报，2009,7(3):261-267.

ITO I, FIXMAN E D, ASAI K, et al. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells[J]. Clin Exp Allergy, 2009, 39(9): 1370-1380.

刘亚尊，虞坚尔，薛征，等. 平喘方及拆方对哮喘模型小鼠pDC/cDC免疫失衡的影响[J]. 中华中医药杂志，2018,33(6):2349-2351.

朱慧华，虞坚尔，张晓峰，等. 平喘方对支气管哮喘模型小鼠巨噬细胞炎性蛋白-1α水平及CD86分子表达的实验研究[J]. 上海中医药杂志，2008,42(9):58-62.

孙敬方. 实验动物方法学[M]. 北京：人民卫生出版社，2001:357.

刘琪军，牟德英. 活血化瘀法治疗支气管哮喘作用机制的研究概况[J]. 中药与临床，2010,1(2):58-59.

陈静，夏永辉，谭丽萍，等. 活血化瘀法对哮喘大鼠气道重塑模型的调控作用研究[J]. 现代中西医结合杂志，2015,24(35):3881-3883.

MURPHY G, ALLAN J A, WILLENBROCK F, et al. The role of the C-terminal domain in collagenase and stromelysin specificity[J]. J Biol Chem, 1992, 267(14): 9612-9618.

沈珊, 梁仁. 中药地龙药理与哮喘气道重建相关性研究[J]. 广东药学院学报, 2004, 20(1): 60-62.

LIN L, LI Q, HAO W, et al. Upregulation of LncRNA Malat1 induced proliferation and migration of airway smooth muscle cells via miR-150-eIF4E/Akt signaling[J]. Front Physiol, 2019(10): 1337.

KARDAS G, DASZYŃSKA-KARDAS A, MARYNOWSKI M, et al. Role of platelet-derived growth factor (PDGF) in asthma as animmunoregulatory factor mediating airway remodeling and possible pharmacological target[J]. Front Physiol, 2020(11): 47.

STAMATIOU R, PARASKEVA E, GOURGOULIANIS K, et al. Cytokines and growth factors promote airway smooth muscle cell proliferation[J/OL]. ISRN Inflamm, 2012[2020-09-02]. https: //www. ncbi. nlm. nih. gov/pmc/articles/PMC3767366/https: //www. ncbi. nlm. nih. gov/pmc/articles/PMC3767366/.

CHENG W, YAN K, CHEN Y, et al. ABCA1 inhibits PDGF-induced proliferation and migration of rat airway smooth muscle cell through blocking TLR2/NF-κB/NFATc1 signaling[J]. J Cell Biochem, 2018, 119(9): 7388-7396.

ZHOU H, WU Q, WEI L, et al. Paeoniflorin inhibits PDGF-BB-induced human airway smooth muscle cell growth and migration[J]. Mol Med Rep, 2018, 17(2): 2660-2664.

LIANG X, WANG J, CHEN W, et al. Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model[J]. Biomed Pharmacother, 2017(95): 275-286.

DRAGICEVIC S, KOSNIK M, DIVAC RANKOV A, et al. The variants in the 3′ untranslated region of the matrix metalloproteinase 9 gene as modulators of treatment outcome in children with asthma[J]. Lung, 2018, 196(3): 297-303.

PIIRILÄ P, LAUHIO A, MAJURI M L, et al. Matrix metalloproteinases-7，-8，-9 and TIMP-1 inthe follow-up of diisocyanate-induced asthma[J]. Allergy, 2010, 65(1): 61-68.

宋晓慧，宋文秀. 基质金属蛋白酶-9与其抑制剂-1与气道重塑的关系[J]. 贵州医药，2015,39(1):80-83.

BARTIS D, MISE N, MAHIDA R Y, et al. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?[J]. Thorax, 2014, 69(8): 760-765.

IJAZ T, PAZDRAK K, KALITA M, et al. Systems biology approaches to understanding epithelial mesenchymal transition (EMT) in mucosal remodeling and signaling in asthma[J]. World Allergy Organ J, 2014, 7(1): 13.

ZHU X, LI Q, HU G, et al. BMS-345541 inhibits airway inflammation and epithelial-mesenchymal transition in airway remodeling of asthmatic mice[J]. Int J Mol Med, 2018, 42(4): 1998-2008.

LI X, ZHOU L, ZHANG Z, et al. IL-27 alleviates airway remodeling in a mouse model of asthma via PI3K/Akt pathway[J]. Exp Lung Res, 2020, 46(3-4): 98-108.

AMRANI Y, PANETTIERI R A, RAMOS-RAMIREZ P, et al. Important lessons learned from studies on the pharmacology of glucocorticoids in human airway smooth muscle cells: too much of a good thing may be a problem[J/OL]. Pharmacol Ther, 2020[2020-09-03]. https: //www. sciencedirect. com/science/article/abs/pii/S0163725820301170?via%3Dihubhttps: //www. sciencedirect. com/science/article/abs/pii/S0163725820301170?via%3Dihub.

Views

303

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Shengxian Wumei decoction on TGF-β1/Smad signaling pathway and airway remodeling in asthma rat model with glucocorticoids intervention

Effects of Pingchuan Recipe on HMGB1/TLR4/NF⁃κB pathway， IKKs and TGF⁃β1 in asthmatic mice

Wang Yiqin’s characteristics of clinical experience in syndrome differentiation and treatment of asthma by using classic prescriptions flexibly

Effect of nanoliposome aerosol inhalation of Guben Pingchuan Formula on immunity and gene expression in asthmatic guinea pigs

Experimental study on capsaicin improving liver damage in mice with alcoholic liver disease by protecting intestinal mucosal barrier

Related Author

No data

Related Institution

Department of Respiratory Medicine,Beijing University of Chinese Medicine Third Affiliated Hospital

Institute of Pediatrics， Shanghai Institute of Traditional Chinese Medicine

Department of Pediatrics， Shanghai Municipal Hospital of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Shanghai University of Traditional Chinese Medicine， Shanghai Key Laboratory of Health Identification and Assessment/Laboratory of Traditional Chinese Medicine Four Diagnostic Information

Liangyuan Traditional Chinese Medicine Hospital

⁰